Copy Link Print Information

Fenofibrate

33 Cited Publications
Customer Review

Based on 33 publication(s) in Google Scholar

Fenofibrate is a selective PPARα agonist with an EC50 of 30 μM. Fenofibrate also inhibits human cytochrome P450 isoforms, with IC50s of 0.2, 0.7, 9.7, 4.8 and 142.1 μM for CYP2C19, CYP2B6, CYP2C9, CYP2C8, and CYP3A4, respectively.

For research use only. We do not sell to patients.

  • Purity: 99.97%
  • CAS No.: 49562-28-9
  • Formula: C20H21ClO4
  • Molecular Weight:360.83
  • Storage:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 1 year , -20°C, 6 months
  • Fenofibrate Chemical Structure
    Fenofibrate Chemical Structure
  • Experimental Validation Results for Fenofibrate
  • Experimental Validation Results for Fenofibrate
  • Experimental Validation Results for Fenofibrate
  • Experimental Validation Results for Fenofibrate
  • Experimental Validation Results for Fenofibrate
CAS No.: 49562-28-9
Size
Price
Stock
Quantity
Amount: USD 0.00
Please select quantity
or
or

* Please select Quantity before adding items.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Other Forms of Fenofibrate:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Find Your Local Distributor Your local distributor: Hycultec GmbHHycultec
  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Protocol
  • Purity & Documentation
  • References
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) Fenofibrate

More
Customer Validation & Images
Bio/Physico-chemical AssayWBHistological Imaging/StainingIn Vivo Efficacy Study
  • Bio/Physico-chemical Assay
  • In Vivo Efficacy Study
  • WB
  • Histological Imaging/Staining
  • Bio/Physico-chemical Assay

All PPAR Isoforms

More

All Cytochrome P450 Isoforms

More
Keywords
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Sign In
Register
Sign in to MedChemExpress
Register New Account

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • Fenofibrate Chemical Structure
    Fenofibrate Chemical Structure
    1/16
  • 1/16

    Fenofibrate purchased from MedChemExpress. Usage Cited in: Cell Metab. 2025 Oct 22:S1550-4131(25)00396-1. [Abstract]

    Customer Validation
     Acyl-CoA relative levels in mouse primary hepatocytes after 4 or 24 h treatment of 326E (100 μM) and Fenofibrate (100 μM).

  • 1/16

    Fenofibrate purchased from MedChemExpress. Usage Cited in: Cell Metab. 2025 Oct 22:S1550-4131(25)00396-1. [Abstract]

    Customer Validation
     After 7-day oral treatment with Fenofibrate (40 mg/kg, calculated based on clinical dose), SB204990 (150 mg/kg), SB204990 (150 mg/kg) plus fenofibrate(40 mg/kg), BA (30 mg/kg), or 326E (30 mg/kg) in MASH mice (induced by Gan diet or CDAA-HFD), hepatic DNL was assessed by 14C-acetate tracing.

  • 1/16

    Fenofibrate purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2025 Apr 15:e2415846. [Abstract]

    Customer Validation
     After treatment with asprosin overexpression plasmid for 24 h, primary hepatocytes were treated with Fenofibrate (100 μM) for 24 h. The protein level of PPARα was analyzed by Western blot.

  • 1/16

    Fenofibrate purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2025 Apr 15:e2415846. [Abstract]

    Customer Validation
     C57BL/6 J mice were fed on HFCDAA and treated with the indicated AAVs. After C57BL/6 J mice were fed on HFCDAA for 4 weeks, mice were injected with vehicle or Fenofibrate (100 mg/kg) for 4 weeks.

  • 1/16

    Fenofibrate purchased from MedChemExpress. Usage Cited in: Hepatology. 2018 Jul;68(1):289-303. [Abstract]

    Customer Validation
     PAQR3 modulates fatty acid oxidation in hepatocytes. The cells in panel A were treated with WY14643 (30 lM) or Fenofibrate (50 lM) for 24 hours, followed by measurement of the fatty acid oxidation rate.

  • Fenofibrate